Kiniksa Pharmaceuticals International (KNSA) Current Deferred Revenue (2022 - 2024)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Current Deferred Revenue came in at $31.8 million in Q4 2024, up 159.45% YoY from $12.3 million in Q1 2024, and up 264991.67% on a QoQ basis from $12000.0 in Q2 2024.
Kiniksa Pharmaceuticals International (KNSA) Current Deferred Revenue (2022 - 2024) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 3 years of Current Deferred Revenue data on file, last reported at $31.8 million in Q4 2024.
- Quarterly Current Deferred Revenue rose 159.45% year-over-year to $31.8 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $31.8 million (up 159.45% YoY) and the FY2024 annual result came in at $31.8 million, up 159.45% from the prior year.
- Current Deferred Revenue rose to $31.8 million in Q4 2024, from $12000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $31.8 million in Q4 2024 to a low of $12000.0 in Q2 2024.
- A 3-year average of $10.5 million and a median of $5.6 million in 2023 frame the typical range for Current Deferred Revenue.
- The widest YoY moves for Current Deferred Revenue: up 159.45% in 2024, down 99.74% in 2024.
- Tracing KNSA's Current Deferred Revenue over 3 years: stood at $26.3 million in 2022, then plunged by 53.36% to $12.3 million in 2023, then jumped by 159.45% to $31.8 million in 2024.
- The last three Current Deferred Revenue figures came in at $31.8 million (Q4 2024), $12000.0 (Q2 2024), and $156000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Kiniksa Pharmaceuticals International | 6.04 Bn | 5.52 Bn | 220.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 31.81 Mn |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 156,000.00 |
| Dec 31, 2023 | 12.26 Mn |
| Sep 30, 2023 | 2.56 Mn |
| Jun 30, 2023 | 4.67 Mn |
| Mar 31, 2023 | 6.50 Mn |
| Sep 30, 2022 | 26.29 Mn |